DALLAS – BeaconEquity.com announces the publication of ‘MiddleBrook Pharmaceuticals, Inc. (MBRK) Engages Morgan Stanley as Its Strategic Advisor’
Investors can view all of the investment articles for free by visiting:
http://www.beaconequity.com/ - Click on News and Commentary
MiddleBrook Pharmaceuticals, Inc. (MBRK) Engages Morgan Stanley as Its Strategic Advisor
The global pharmaceutical market is forecast to grow to US$897 billion in 2011. According to IMS Health’s 2008 Global Pharmaceutical Market and Therapy Forecast, the global pharmaceutical market is expected to grow at a 5-6% pace in 2008, compared with 6-7% in 2007, with global pharmaceutical sales forecast to expand to US$735 - 745 billion this year. MiddleBrook Pharmaceuticals, Inc. (MBRK) is a company that engages in the development and commercialization of anti-infective drug products for the treatment of infectious diseases. It develops a proprietary, once-a-day pulsatile delivery technology called PULSYS.
MiddleBrook Pharmaceuticals' pulsatile product candidates include Amoxicillin PULSYS for adults and adolescents with pharyngitis and/or tonsillitis; and Keflex PULSYS product candidate, based on the antibiotic cephalexin, which is in Phase I clinical trials for skin and skin structure infections. In addition, MiddleBrook Pharmaceuticals sells its Keflex products in both capsule and powder formulations for the treatment of skin and skin structure infections, and upper respiratory tract infections primarily through pharmaceutical distributors and wholesalers to physicians, hospitals, and pharmacies in the United States.
To read the entire article visit http://www.beaconequity.com/ – Click on News and Commentary
Join the fastest growing investor community at:
http://www.stockhideout.com
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.beaconequity.com/
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
